Epidemiology of Parkinson’s disease

Journal of Neural Transmission

Volumn 124, Issue 8, 2017, Pages 901-905

  Tysnes, Ole Bjørn ^a   Storstein, Anette ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Diagnostic criteria; Epidemiology; Non motor symptoms; Parkinson s disease

Indexed keywords

ASYMPTOMATIC DISEASE; HUMAN; INCIDENCE; NEUROPATHOLOGY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

HUMANS; PARKINSON DISEASE;

EID: 85011299976     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-017-1686-y     Document Type: Review

References (36)

1. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57(3):456–462
2. Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.1136/jnnp.2008.168211
3. Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord 23:1–9. doi:10.1016/j.parkreldis.2015.12.008
4. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211
5. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. doi:10.1016/S1474-4422(06)70471-9
6. de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, Hofman A (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology 45(12):2143–2146
7. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54(11 Suppl 5):S21–S23
8. Gaare JJ, Skeie GO, Tzoulis C, Larsen JP, Tysnes OB (2016). Familial aggregation of Parkinson\s disease may affect progression of motor symptoms and dementia. Mov Disord. doi:10.1002/mds.26856
9. Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P (2014) Non-motor symptoms of Parkinson’s disease a review from the past. J Neurol Sci 338(1–2):30–33. doi:10.1016/j.jns.2014.01.002
10. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
11. Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 365(9457):415–416. doi:10.1016/S0140-6736(05)17830-1
12. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22(6):839–842. doi:10.1002/mds.21413
13. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57(8):1497–1499
14. Jankovic M, Svetel M, Kostic V (2015) Frequency of REM sleep behavior disorders in patients with Parkinson’s disease. Vojnosanit Pregl 72(5):442–446
15. Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3
16. Larsen JP, Dupont E, Tandberg E (1994) Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89(4):242–251
17. Lee PC, Liu LL, Sun Y, Chen YA, Liu CC, Li CY, Yu HL, Ritz B (2016) Traffic-related air pollution increased the risk of Parkinson’s disease in Taiwan: a nationwide study. Environ Int 96:75–81. doi:10.1016/j.envint.2016.08.017
18. Lesage S, Brice A (2012) Role of mendelian genes in “sporadic” Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S66–S70. doi:10.1016/S1353-8020(11)70022-0
19. Lill CM (2016) Genetics of Parkinson’s disease. Mol Cell Probes 30(6):386–396. doi:10.1016/j.mcp.2016.11.001
20. Linder J, Stenlund H, Forsgren L (2010) Incidence of Parkinson’s disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 25(3):341–348. doi:10.1002/mds.22987
21. Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH (2016) Time trends in the prevalence and incidence of Parkinson’s disease in Taiwan: a nationwide, population-based study. J Formos Med Assoc 115(7):531–538. doi:10.1016/j.jfma.2015.05.014
22. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015a) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. doi:10.1002/mds.26424
23. Postuma RB, Gagnon JF, Bertrand JA, Genier Marchand D, Montplaisir JY (2015b) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84(11):1104–1113. doi:10.1212/WNL.0000000000001364
24. Rana HQ, Balwani M, Bier L, Alcalay RN (2013) Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genet Med Off J Am Coll Med Genet 15(2):146–149. doi:10.1038/gim.2012.107
25. Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86(6):566–576. doi:10.1212/WNL.0000000000002350
26. Rocca WA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM (2001) Time trends in the incidence of Parkinsonism in Olmsted County, Minnesota. Neurology 57(3):462–467
27. Savica R, Cannon-Albright LA, Pulst S (2016a) Familial aggregation of Parkinson disease in Utah: a population-based analysis using death certificates. Neurol Genet 2(2):e65. doi:10.1212/NXG.0000000000000065
28. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2016b) Time trends in the incidence of Parkinson disease. JAMA Neurol 73(8):981–989. doi:10.1001/jamaneurol.2016.0947
29. Seljeseth YM, Vollset SE, Tysnes O-B (2000) Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 55:1262–1266
30. Stirpe P, Hoffman M, Badiali D, Colosimo C (2016) Constipation: an emerging risk factor for Parkinson’s disease? Eur J Neurol. doi:10.1111/ene.13082
31. Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343(24):1765–1770. doi:10.1056/NEJM200012143432404
32. Svensson E, Henderson VW, Borghammer P, Horvath-Puho E, Sorensen HT (2016) Constipation and risk of Parkinson’s disease: a Danish population-based cohort study. Parkinsonism Relat Disord 28:18–22. doi:10.1016/j.parkreldis.2016.05.016
33. Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes. JAMA Neurol 71(4):499–504. doi:10.1001/jamaneurol.2013.6233
34. Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5(1):75–86. doi:10.1016/S1474-4422(05)70285-4
35. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022
36. von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R (2005) Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol 15(4):473–490. doi:10.1016/j.euroneuro.2005.04.007